Patents by Inventor Pascal Lopez

Pascal Lopez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7335471
    Abstract: Mutant RNA polymerases of phagic origin in which the peptide chain is modified by substitution, deletion or addition of at least one amino acid, the modification having the effect of reducing the sensitivity of the RNA polymerases to the initial transcription sequence of the DNA sequence coding for the RNA, for a method for production of the RNA, or proteins coded by the RNA, from given nucleotide sequences, comprising a sequence of DNA coding for the RNA, the transcription of which is placed under the control of a promoter recognised by wild-type RNA polymerases and the mutant RNA polymerases as above. The method has a higher yield of RNA than the yield obtained when using the wild-type RNA polymerases in the presence of the same non-consensual ITS as that found in the sequence of DNA coding for the RNA.
    Type: Grant
    Filed: March 19, 2002
    Date of Patent: February 26, 2008
    Assignee: Centre National de la Recherche Scientifique
    Inventors: Jean Guillerez, Pascal Lopez, Marc Dreyfus
  • Publication number: 20040126842
    Abstract: A process for producing predetermined recombinant polypeptides or proteins, comprising expressing the polypeptides or proteins in Escherichia coli (E. coli) strains whose gene coding RNase E comprises a mutation such that the enzyme produced upon expression of this mutated gene exhibits reduced activity for degrading the messenger RNA (m-RNA) encoding the polypeptides or proteins, compared to bulk mRNA, the mutation not significantly affecting growth of the E. coli strains, and wherein the mutation corresponds to the substitution or deletion of one up to all the nucleotides located in the region delimited by the nucleotide at position 2193 and the nucleotide at position 2975 of the DNA sequence coding the RNase E represented by SEQ ID NO: 1.
    Type: Application
    Filed: September 5, 2003
    Publication date: July 1, 2004
    Inventors: Marc Dreyfus, Pascal Lopez, Agamemnon J. Carpousis
  • Publication number: 20040091854
    Abstract: Mutant RNA polymerases of phagic origin in which the peptide chain is modified by substitution, deletion or addition of at least one amino acid, the modification having the effect of reducing the sensitivity of the RNA polymerases to the initial transcription sequence of the DNA sequence coding for the RNA, for a method for production of the RNA, or proteins coded by the RNA, from given nucleotide sequences, comprising a sequence of DNA coding for the RNA, the transcription of which is placed under the control of a promoter recognised by wild-type RNA polymerases and the mutant RNA polymerases as above. The method has a higher yield of RNA than the yield obtained when using the wild-type RNA polymerases in the presence of the same non-consensual ITS as that found in the sequence of DNA coding for the RNA.
    Type: Application
    Filed: December 23, 2003
    Publication date: May 13, 2004
    Inventors: Jean Guillerez, Pascal Lopez, Marc Dreyfus
  • Publication number: 20040029231
    Abstract: The invention concerns the use of Escherichia coli (E. coli) strains whereof the gene coding for the Rnase E comprises a mutation such that the enzyme produced when said mutated gene is expressed no longer has a degrading activity on mRNA, said mutation more significantly not affecting the growth of E. coli strains, for implementing a method for producing specific exogenous recombinant polypeptides.
    Type: Application
    Filed: August 5, 2003
    Publication date: February 12, 2004
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Marc Freyfus, Pascal Lopez
  • Patent number: 6632639
    Abstract: The invention concerns the use of Escherichia coli (E. coli) strains whereof the gene coding for the Rnase E comprises a mutation such that the enzyme produced when said mutated gene is expressed no longer has a degrading activity on mRNA, said mutation more significantly not affecting the growth of E. coli strains, for implementing a method for producing specific exogenous recombinant polypeptides.
    Type: Grant
    Filed: May 17, 2001
    Date of Patent: October 14, 2003
    Assignee: Centre National de la Recherche Scientifique
    Inventors: Marc Dreyfus, Pascal Lopez